Top 50 Biotechnology VC Funds & Investors in Sweden (September 2026)
For AI agents: Short investor table (Markdown), Detailed investor list (Markdown)
| Investor | Relevant Deals | Geography | Stage | Focus | Round Size |
|---|---|---|---|---|---|
|
Chalmers Ventures AB
VC Fund
|
29 | Sweden | Pre-Seed, Seed, Venture - Series Unknown | Software, Biotechnology, Information Technology | $5.8k–$3.5M |
|
Almi Invest
VC Fund
|
28 | Sweden, Norway, United States | Venture - Series Unknown, Seed | Software, Health Care, Information Technology | $221k–$3.5M |
|
Industrifonden
VC Fund
|
17 | Sweden, United States, Denmark | Series A, Venture - Series Unknown | Biotechnology, Software, Information Technology | $2.5M–$21M |
|
Sciety
VC Fund
|
14 | Sweden, Ukraine | Seed, Series A, Venture - Series Unknown | Health Care, Biotechnology, Medical | $125k–$6.9M |
|
Navigare Ventures
VC Fund
|
8 | Sweden, Denmark | Seed, Series A, Series B | Biotechnology, Manufacturing, Energy | $470k–$22M |
|
Novo Holdings
VC Fund
|
6 | United States, Denmark, United Kingdom | Series A, Series B, Series C | Biotechnology, Health Care, Medical | $9.5M–$135M |
|
HealthCap
VC Fund
|
5 | United States, Sweden, France | Series B, Series A | Biotechnology, Health Care, Medical | $6M–$92M |
|
Karolinska
VC Fund
|
5 | Sweden, Denmark, United States | Venture - Series Unknown, Seed | Biotechnology, Health Care, Pharmaceutical | $3.2M–$10M |
|
Norrsken VC
VC Fund
|
4 | Sweden, United Kingdom, Germany | Seed, Series A, Venture - Series Unknown | Software, Food and Beverage, Artificial Intelligence | $893k–$156M |
|
SEB Venture Capital
VC Fund
|
4 | Sweden, Denmark, United Kingdom | Series A, Series B | Software, Information Technology, FinTech | $1.2M–$23M |
|
FBG Invest
VC Fund
|
3 | Sweden | Seed | Biotechnology, Manufacturing, Food Processing | $1.3M–$9.1M |
|
Flerie Invest
VC Fund
|
3 | Sweden, United States, United Kingdom | Series A, Venture - Series Unknown, Series B | Biotechnology, Health Care, Pharmaceutical | $2.5M–$75M |
|
Hadean Ventures
VC Fund
|
3 | Sweden, Norway, Austria | Series A, Series B, Venture - Series Unknown | Biotechnology, Health Care, Medical | $2M–$79M |
|
Fåhraeus Startup and Growth
VC Fund
|
3 | Sweden, Denmark, Finland | Seed, Venture - Series Unknown, Series A | Medical, Health Care, Biotechnology | $851k–$7.3M |
|
Boehringer Ingelheim Venture Fund
VC Fund
|
3 | United States, Germany, Switzerland | Series A, Series B, Seed | Biotechnology, Health Care, Therapeutics | $1.8M–$50M |
|
Crowberry Capital
VC Fund
|
3 | Iceland, Denmark, Finland | Seed, Series A, Pre-Seed | Software, Gaming, Health Care | $400k–$17M |
|
Voima Ventures
VC Fund
|
3 | Finland, Sweden, Norway | Seed, Pre-Seed, Series A | Biotechnology, Health Care, Artificial Intelligence | $464k–$30M |
|
Bånt AB
VC Fund
|
3 | Sweden | Seed | Biotechnology, Manufacturing, Food Processing | $1.3M–$9.1M |
|
EIR Ventures
VC Fund
|
3 | Denmark, Sweden, United States | Series A, Seed | Biotechnology, Health Care, Therapeutics | $20M–$73M |
|
BackingMinds
VC Fund
|
3 | Sweden, Denmark, Finland | Seed, Venture - Series Unknown, Pre-Seed | Software, SaaS, Energy | $826k–$40M |
|
I Love Lund
VC Fund
|
3 | Sweden | Venture - Series Unknown, Pre-Seed, Seed | Biotechnology, Medical, Forestry | $38k–$2.2M |
|
Inventure
VC Fund
|
3 | Finland, Sweden, United States | Seed, Series A, Series B | Software, Information Technology, Health Care | $549k–$25M |
|
Partnerinvest Norr
VC Fund
|
3 | Sweden, United States | Seed, Venture - Series Unknown | Software, Manufacturing, Information Technology | $326k–$6.1M |
|
Gunnar Nilsson Cancer Foundation
VC Fund
|
2 | Sweden | Seed, Series A | Medical, Genetics, Biotechnology | |
|
Glass Wall Syndicate
VC Fund
|
2 | United States, India, Sweden | Seed, Pre-Seed, Series C | Biotechnology, Food and Beverage, Health Care | $845k–$5.7M |
|
Additio Investment Group
VC Fund
|
2 | United Kingdom, Sweden | Series A | Health Care, Biotechnology, Medical | $4.3M–$12M |
|
Faro Capital
VC Fund
|
2 | Sweden, United States | Series A, Seed, Venture - Series Unknown | Biotechnology, Gaming, Medical | $2.8M–$25M |
|
LU Holding
VC Fund
|
2 | Sweden | Seed, Angel, Pre-Seed | Biotechnology, Software, Medical Device | |
|
Colibri Ventures
VC Fund
|
2 | Sweden, Mexico | Seed, Series A, Venture - Series Unknown | Gaming, Finance, Wellness | $6M–$6M |
|
Nordic Science Investments
VC Fund
|
2 | Finland, Sweden, United States | Seed, Pre-Seed, Series A | Biotechnology, Medical, Health Diagnostics | $373k–$4.6M |
|
ARCH Venture Partners
VC Fund
|
2 | United States, China, United Kingdom | Series A, Series B, Series C | Biotechnology, Health Care, Therapeutics | $8.4M–$230M |
|
Segulah Medical Acceleration
VC Fund
|
2 | Sweden, United Kingdom, Germany | Series D, Series A, Seed | Health Care, Medical Device, Biotechnology | $8.5M–$245M |
|
Noaber
VC Fund
|
2 | The Netherlands, Israel, Germany | Seed, Series A, Pre-Seed | Health Care, Medical, Fitness | $423k–$20M |
|
Life Science Invest
VC Fund
|
2 | Sweden | Seed, Pre-Seed | Medical, Biotechnology, Biopharma | $310k–$4.6M |
|
Länsförsäkringar
VC Fund
|
2 | Sweden | Seed, Pre-Seed, Post-IPO Equity | Real Estate, Biotechnology, Manufacturing | $484k–$107M |
|
Kale United
VC Fund
|
2 | Sweden, United Kingdom, Canada | Seed, Pre-Seed | Food and Beverage, Food Processing, Biotechnology | $100k–$2.5M |
|
Bertebos Foundation
VC Fund
|
2 | Sweden | Seed | Biotechnology, Manufacturing, Food Processing | |
|
Nina Capital
VC Fund
|
2 | United States, United Kingdom, Germany | Seed, Pre-Seed, Series A | Health Care, Artificial Intelligence, Software | $529k–$21M |
|
LIU Invest
VC Fund
|
2 | Sweden | Seed, Pre-Seed | Biotechnology, Information Technology, AgTech | $88k–$1.4M |
|
Plantbase Foundation
VC Fund
|
2 | Sweden | Seed | Biotechnology, Manufacturing, Food Processing | |
|
KTH Holding
VC Fund
|
1 | Sweden | Seed, Pre-Seed | Software, Information Technology, Biotechnology | |
|
Nordic Foodtech VC
VC Fund
|
1 | Finland, Sweden, Denmark | Seed, Series A | Biotechnology, Life Science, Water | |
|
Knutsson Holdings AB
VC Fund
|
1 | Sweden, Germany | Series C | Gaming, Billing, Parking | |
|
Sätila Holding
VC Fund
|
1 | Sweden | Biopharma, Health Care, Biotechnology | ||
|
Falkenbergs Sparbanks Foundation
VC Fund
|
1 | Sweden | Biotechnology, Manufacturing, Food Processing | ||
|
LUBio Science
VC Fund
|
1 | Sweden | Therapeutics, Biotechnology, Medical Device | ||
|
Kurma Partners
VC Fund
|
1 | France, Switzerland, Spain | Series A, Seed, Series B | Health Care, Biotechnology, Medical | $2.7M–$98M |
|
Idinvest Partners
VC Fund
|
1 | France, United States, Germany | Series A, Series B, Venture - Series Unknown | Software, Health Care, Biotechnology | $3.9M–$66M |
|
Irrus Investments
VC Fund
|
1 | Ireland, Sweden, United States | Seed, Venture - Series Unknown, Series A | Health Care, Medical Device, Biotechnology | $713k–$24M |
|
Sofinnova Partners
VC Fund
|
1 | France, United States, United Kingdom | Series A, Series B, Series C | Biotechnology, Health Care, Medical | $7M–$105M |
| Access all 325 VC funds in Sweden Biotechnology startups. | |||||
Access 48,091 investors
822 industries, 177 countries. Updated daily. Emails and phones included.
Browse database — It's Free!Investor list
We are a leading tech investor & venture builder in the Nordics. Taking deep tech from lab to market.WELCOMEINVESTMENTS
Show more...Investment focus
- Industry: Software, Biotechnology, Information Technology
- Stage:Pre-Seed, Seed, Venture - Series Unknown
- Geography: Sweden
Investor stats
- Total investments: 280
- Round size: Seed $274k–$2.3M; Pre-Seed $5.8k–$349k; Venture - Series Unknown $357k–$3.5M
- Lead/follow: 45% lead, 55% follow
Portfolio highlights
- Ambidex AB — helps food retailers create new revenue streams on their refrigeration systems by stabilizing the electricity grid.
- Solinide Photonics — Solinide Photonics is a technological company spun out of Chalmers University of Technology. It develops ultra-efficient silicon nitride-based photonic circuits and microcomb technologies.
- InfiniNode Technologies AB — InfiniNode is a semiconductor IP company that seeks to enable efficient data movement in future compute systems.
Almi Invest is Sweden’s most active early-stage venture capital firm, investing in scalable startups across Sustainability, Industry, Tech, and Life Science.We invest from pre-seed to Series A, always co-investing with independent private investors to accelerate innovation and long-term success. Our portfolio spans sustainable solutions,industrial innovation, deep tech, SaaS, and life science, supporting startups that drive economic and environmental progress.With €430 million under management and over 1,000 investments since 2009, we have backed leading companies like MIPS, Tobii, and Neo4j, with notable exits to Google, Apple, Microsoft, and Qlik.Beyond capital, we offer engaged ownership, providing strategic guidance, active board participation, and access to an extensive investor network.Almi Invest is part of the Almi Group and is funded by the European Regional Development Fund, Almi AB, and regional partners.
Show more...Investment focus
- Industry: Software, Health Care, Information Technology
- Stage:Venture - Series Unknown, Seed
- Geography: Sweden, Norway, United States
Investor stats
- Total investments: 513
- Round size: Seed $221k–$2.2M; Venture - Series Unknown $326k–$3.5M
- Lead/follow: 33% lead, 67% follow
- Last fund: Likely still investing — raised $64M in 2024
Portfolio highlights
- Brighteco — Brighteco is an innovative and value-driven Born Circular startup that offers Light as a Service. All Brighteco hardware are build modular and circular from e.g reused computer screens.
- Ambidex AB — helps food retailers create new revenue streams on their refrigeration systems by stabilizing the electricity grid.
- Xaga Surgical — Xaga Surgical aims to minimize the risk of infections by inventing safer medical needles.
Industrifonden is a Nordic evergreen venture capital firm with a fund size of $600m, that focuses on early-stage technology and life science companies with international potential. The company works long term with the entrepreneurs we invest in, and have a strong track record of building game changing companies. Industrifonden-backed companiesinclude tech companies Qlik, Arcam, Soundtrack Your Brand, Fishbrain, and life science companies CellaVision, Oncopeptides and AMRA.
Show more...Investment focus
- Industry: Biotechnology, Software, Information Technology
- Stage:Series A, Venture - Series Unknown
- Geography: Sweden, United States, Denmark
Investor stats
- Total investments: 202
- Round size: Series A $3.3M–$21M; Venture - Series Unknown $2.5M–$21M
- Lead/follow: 40% lead, 60% follow
Portfolio highlights
- Avtal24 — Avtal24 offers in an easily accessible manner agreements for both private individuals and companies. They believe in making the law available to everyone and they want everyone to have access to legal security. With us, you write agreements online or together with a lawyer by phone. Always at a fixed price. With high legal expertise, innovativetechnology and great focus on customer benefit and offer the market's most accessible legal services.Avtal24 was founded in 2004 and is headquartered in Stockholm, Sweden.
- Fibbl — Enhance your e-commerce store with high-quality 3D product visualization for footwear. Scale 3D, AR, and virtual try-on experiences to boost engagement and conversions.
- Trackpaw Scientific — Contributing to the development of safe and effective pharmaceuticals at increased speed and quality by digitalising the preclinical study landscape.
Whether you are an investor or entrepreneur, partner with Sciety to achieve impactful returns and elevate your life science business in the Nordics.
Show more...Investment focus
- Industry: Health Care, Biotechnology, Medical
- Stage:Seed, Series A, Venture - Series Unknown
- Geography: Sweden, Ukraine
Investor stats
- Total investments: 47
- Round size: Seed $125k–$2.3M; Series A $457k–$6.5M; Venture - Series Unknown $1.6M–$6.9M
- Lead/follow: 91% lead, 9% follow
Portfolio highlights
- NEOGAP Therapeutics — NEOGAP Therapeutics is a clinical-stage biopharmaceutical startup focused on immuno oncology. Their pharmaceutical product, personalized tumor trained lymphocytes, offers even one customized cell treatment that is meant to precisely target and destroy cancer in a tailored environment, with very minor side effects.
- Everdrone — Advanced drone operations for public safety and emergency response
- Single Technologies — SINGLE TECHNOLOGIES develops a new type of single-molecule-sensitive 3D sequencing system.They provide single-molecule detection, fiber optics, 3D imaging, genomics, sequencing, and 3-D Seq.
Novo Holdings is a world-leading life science investor with a focus on creating long-term value.
Show more...Investment focus
- Industry: Biotechnology, Health Care, Medical
- Stage:Series A, Series B, Series C
- Geography: United States, Denmark, United Kingdom
Investor stats
- Total investments: 398
- Round size: Series A $9.5M–$133M; Series B $15M–$135M; Series C $30M–$118M
- Lead/follow: 39% lead, 61% follow
- Last fund: May invest from a new fund soon — raised $165M in 2018
Portfolio highlights
- Santaris Pharma — Spearheading RNA molecule research since 2003, our site in Copenhagen is focused on leading chemistry for targeting any type of transcribed RNA using short synthetic single-strand oligonucleotides. Here, our experts in the field pioneered our core technology platform of locked nucleic acids (LNA) and antisense oligonucleotides (ASO).
- PTC Therapeutics — Translating Science. Transforming Lives.
- SCHOTT Poonawalla — SCHOTT Poonawalla is a manufacturer of pharmaceutical containers, made of neutral glass tubing. The company provides parenteral packaging systems crafted from tubular glass, serving the pharmaceutical industry with a broad range of products including vials, pre-fillable syringes, ampoules, and cartridges.
HealthCap, a life science investor and company creator. Our motivation is to find innovative ideas and invest that could impact healthcare and society.
Show more...Investment focus
- Industry: Biotechnology, Health Care, Medical
- Stage:Series B, Series A
- Geography: United States, Sweden, France
Investor stats
- Total investments: 141
- Round size: Series A $6M–$73M; Series B $12M–$92M
- Lead/follow: 26% lead, 74% follow
- Last fund: Likely still investing — raised $179M in 2024
Portfolio highlights
- Neobiomics — Neobiomics is a Swedish life-science company that develops nutritional products for preterm infants and neonatal care. Its best-known products include ProPrems® and NeoMega36®.
- AMRA Medical — AMRA Medical is a digital health company transforming medical research and clinical care using rapid whole-body MRI technology.
- Ultragenyx Pharmaceutical — Ultragenyx is focused on developing first-ever approved treatments for rare and ultrarare diseases and moving the rare disease community forward.
Karolinska Development aims to create value for patients, researchers, investors and society by developing innovations from world class science into products that can be sold or out-licensed with high returns. The business model is to: SELECT the most commercially attractive medical innovations; DEVELOP innovations to the stage where the greatestreturn on investment can be achieved; and COMMERCIALIZE the innovations through the sale of companies or out-licensing of products.Karolinska Development has developed a well-structured selection process to identify the most commercially attractive medical innovations screened by KIAB. Pharmaceutical development is a high-risk enterprise. In most cases, development projects fail because of side effects or insufficient efficacy. Successful selection of innovations is fundamental to Karolinska Development’s business model, which makes the inflow of new projects crucial. One key to success lies in selecting those innovations that can be developed from scientific findings to products and have significant commercial potential. To date, over 1,300 projects have been screened by KIAB.The portfolio companies are often founded together with the innovators and are initially operated as virtual companies with few or no employees. During the first six to twelve months, the companies normally have minimal fixed costs and technological development is outsourced.The innovator, who is often employed at an academic institution, normally participates as a board member and scientific advisor. The CEO of a portfolio company cooperates closely with a representative of Karolinska Development, who in most cases is also a board member of the company. The companies are capitalized to reach their next milestone, usually within a period of six to eighteen months. Development projects are continuously monitored, and those that do not meet their stipulated targets are discontinued. In the first three to four years, a portfolio company’s operating expenses are often limited to a few million Swedish kronor per year, which cover the cost of external studies and the salary of the staff. In subsequent years, Karolinska Development and other investors play an important role recruiting key expertise to the companiesKarolinska Development intends to realize value by exiting portfolio companies or through out-licensing of projects. Such transactions (especially out-licensing) are often structured as single upfront payments followed by payments based on predetermined milestones and royalties on sales. Although Karolinska Development has a flexible exit strategy, pharmaceutical products are, for two reasons, preferably exited at Phase II. First a successful Phase II study indicates that the pharmaceutical has an effect on patients, which is an important value-enhancing factor when negotiating out-licensing or sales. Secondly, finalizing product development and undertaking Phase III clinical trials frequently requires very large patient populations. In many cases this requires much greater resources than those available at Karolinska Development but these can be found in established pharmaceutical companies. Several licensing deals were closed in 2011 involving projects with a similar focus and development phase to Karolinska Development's projects.
Show more...Investment focus
- Industry: Biotechnology, Health Care, Pharmaceutical
- Stage:Venture - Series Unknown, Seed
- Geography: Sweden, Denmark, United States
Investor stats
- Total investments: 32
- Round size: Venture - Series Unknown $3.2M–$10M
- Lead/follow: 34% lead, 66% follow
Portfolio highlights
- BOOST Pharma — BOOST Pharma is developing BT-101, an off-the-shelf therapy for early intervention in children with severe osteogenesis imperfecta (OI).
- Modus Therapeutics — Modus Therapeutics is a Swedish drug development company developing sevuparin – a novel drug to treat people suffering from Sickle Cell Disease – a painful, inherited blood disorder affecting millions of people around the globe.
- Umecrine Cognition — Umecrine Cognition is a Swedish clinical-stage pharmaceutical company developing a novel class of drugs to treat neurological disorders of the brain.
We are a venture capital fund investigating in Start-Ups solving the worlds biggest problems while building massive businesses.
Show more...Investment focus
- Industry: Software, Food and Beverage, Artificial Intelligence
- Stage:Seed, Series A, Venture - Series Unknown
- Geography: Sweden, United Kingdom, Germany
Investor stats
- Total investments: 108
- Round size: Seed $893k–$14M; Series A $4.4M–$56M; Venture - Series Unknown $1.1M–$156M
- Lead/follow: 31% lead, 69% follow
- Last fund: Likely still investing — raised $346M in 2024
Portfolio highlights
- Biorce — Meet the world's first AI clinical trials assistant! We bring innovative technologies to revolutionize healthcare and drug development faster & more efficiently
- Verse — Define & achieve your financial and emissions reduction goals with Aria, a software platform that helps companies buy and manage clean power.
- Endra — Endra is a purpose-built platform for modern MEP engineering. Generate 3D models and drawings, sync with Revit and enjoy coordinated design workflows.
SEB Venture Capital is a Fintech investor that helps entrepreneurs and innovators launch and grow profitable businesses. They primarily serve as a strategic corporate venture focused on Fintech investments, with the option of partnering with SEB. They are also on the hunt for game-changing inventive solutions to new technologies that will make thefinancial industry smarter, safer, and more environmentally responsible, as well as more user-friendly. They also function as an evergreen fund, giving them the flexibility and staying strength to focus on long-term wealth development depending on what is best for the firm and its shareholders.
Show more...Investment focus
- Industry: Software, Information Technology, FinTech
- Stage:Series A, Series B
- Geography: Sweden, Denmark, United Kingdom
Investor stats
- Total investments: 77
- Round size: Series A $1.2M–$7.4M; Series B $2.2M–$23M
- Lead/follow: 44% lead, 56% follow
- Last fund: May invest from a new fund soon — raised $300M in 1995
Portfolio highlights
- Apica — Apica provides the most effective technology for optimizing the performance of cloud and mobile applications. The Apica WebExcellence Suite offers companies and developers alike easy-to-use, cloud-based load testing and web performance monitoring tools to test applications for maximum capacity, daily performance, improved load times, and protectionfrom peak load.
- MobileTag — Mobile Tag, the European leader in mobile barcode solutions, continues to innovate with the launch of its latest application: mobiletag Universal Reader and shopping.Mobile Tag is behind the creation of the flashcode, the standard 2D barcode used by operators in France. This type of Datamatrix barcode is used by the biggest companies indisplay, transportation, distribution, the pharmaceutical industry, and more.Mobile Tag has always tried to develop new technology from the consumer's point of view, and the mobiletag Universal Reader & shopping is no exception.The concept behind this application is to send, receive and share information and best prices to everyone and for everyone through all standardized barcodes.Scanning a barcode with your mobile phone is simply taking a picture of it with your phone, using the mobiletag application. Mobile tag is free!
- CorPower Ocean — CorPower Ocean AB was founded in 2009 to develop high efficiency Wave Energy Converters (WECs).CorPower's Wave Energy Converters deliver five times higher annual energy output per ton of device compared to previously known wave power solutions. The step-change improvement in performance and efficiency allows a Cost-of-Energy that cancompete with offshore wind. The products are currently in pilot with Iberdrola. CorPower has assembled a team with extensive experience in energy generation, design and manufacturing of production equipment, system engineering as well as the market expertise to allow us to continue transforming the technology of tomorrow into renewable energy applications of today.
Access 48,091 investors
822 industries, 177 countries. Updated daily. Emails and phones included.
Browse database — It's Free!FBG Invest
Show more...Investment focus
- Industry: Biotechnology, Manufacturing, Food Processing
- Stage:Seed
- Geography: Sweden
Investor stats
- Total investments: 3
- Round size: Seed $1.3M–$9.1M
- Lead/follow: 0% lead, 100% follow
Portfolio highlights
- Mycorena — Mycorena is a fungi-based, next-generation vegan protein and food manufacturing solution to plants, using significantly less resources. Mycorena was established in 2017 and is headquartered in Gothenburg, Sweden.
Flerie is an active long-term life science investor, focusing on biotech and pharmaceutical investments globally.
Show more...Investment focus
- Industry: Biotechnology, Health Care, Pharmaceutical
- Stage:Series A, Venture - Series Unknown, Series B
- Geography: Sweden, United States, United Kingdom
Investor stats
- Total investments: 27
- Round size: Series A $2.5M–$21M; Series B $12M–$75M; Venture - Series Unknown $4.5M–$47M
- Lead/follow: 56% lead, 44% follow
Portfolio highlights
- AnaCardio — AnaCardio develops drugs targeting a novel mechanism that improves cardiac contractility and aims to improve clinical outcomes in heart failure.
- Nanologica — Nanologica combines unique know-how in the field of materials technology with a genuine interest in solving real problems in life science. The company works with nanoporous silica which has properties that are attractive in a wide variety of applications. In order to succeed, development work is carried out in close dialog with customers.Nanologica is unique in that it is a world leader in controlling the form, type of porosity and surface area of particles of silica. This competence can be used to produce particles that have the potential to solve problems in diverse application areas. The company’s core competency has been developed and expanded in twoareas of application in particular: drug delivery on the one hand and on the other chromatography, a technology used for the separation and purification of products on the market and in development.The starting point for Nanologica’s work is the material sciences, a field in which the company’s founder has developed and patented completely new materials. The initial research was based at Stockholm University and the Ångström laboratories atUppsala University.
- KAHR medical — KAHR Medical ("KAHR") is pioneering the development of "third generation biological drugs," a unique class of proprietary fusion-protein molecules with clear and far-reaching advantages. KAHR's technology represents a paradigm shift in protein-based pharmaceuticals that will significantly expand available treatment optionsfor cancer and autoimmune disorders.
Hadean Ventures is a life science fund manager that invests in life science companies across europe with a particular focus on the nordic region. The funds are backed by leading private and institutional investors. Hadean Ventures has offices in oslo and stockholm and collaborates with world-class academic institutions and start-up hubs across theregion
Show more...Investment focus
- Industry: Biotechnology, Health Care, Medical
- Stage:Series A, Series B, Venture - Series Unknown
- Geography: Sweden, Norway, Austria
Investor stats
- Total investments: 34
- Round size: Series A $4.2M–$79M; Series B $4.5M–$75M; Venture - Series Unknown $2M–$29M
- Lead/follow: 47% lead, 53% follow
- Last fund: Likely still investing — raised $168M in 2021
Portfolio highlights
- Step Pharma — Step Pharma is a spin-off of Imagine Institute stemming from Pr. Alain Fischer’s research on genetic immunodeficiencies. Step Pharma is a joint venture between Imagine, a research and innovative healthcare institute, Sygnature Discovery, a leading provider of integrated drug discovery resource and expertise, and Kurma Partners, a major player inthe funding of healthcare and biotechnology in Europe.
- ARTHEx Biotech — ARTHEx Biotech S.L. is a spin-off company of the University of Valencia that is developing advanced RNA treatments against genetic diseases.
- TargED Biopharmaceuticals — TargED Biopharmaceuticals is a biotechnology company that develops first-in-class biological drugs to improve treatment of thrombosis.TargED stands for Targeted Enzyme Delivery. Their biological drugs are unique by using small antibodies (“VhH”) to deliver enzymes to sites of thrombosis, enabling ‘targeted’ thrombolysis.
Fåhraeus Startup and Growth is a venture capital fund that invests early in life science and tech companies.
Show more...Investment focus
- Industry: Medical, Health Care, Biotechnology
- Stage:Seed, Venture - Series Unknown, Series A
- Geography: Sweden, Denmark, Finland
Investor stats
- Total investments: 14
- Round size: Seed $851k–$2.7M; Series A $1.8M–$5.9M; Venture - Series Unknown $1.1M–$7.3M
- Lead/follow: 43% lead, 57% follow
Portfolio highlights
- Aplagon — Aplagon is committed to bringing unique, effective antithrombotic medicines with important safety advantages to patients with unmet needs.
- Fida Biosystems — Quantification and characterisation of complex biology made simple. Study molecular interactions in solution, with only nanoliters of sample. Used by industry leaders.
- Trackpaw Scientific — Contributing to the development of safe and effective pharmaceuticals at increased speed and quality by digitalising the preclinical study landscape.
Discover Boehringer Ingelheim Venture Fund. We invest in groundbreaking science to transform care. Explore our mission and join us in advancing medicine
Show more...Investment focus
- Industry: Biotechnology, Health Care, Therapeutics
- Stage:Series A, Series B, Seed
- Geography: United States, Germany, Switzerland
Investor stats
- Total investments: 108
- Round size: Seed $1.8M–$20M; Series A $3.8M–$34M; Series B $11M–$50M
- Lead/follow: 48% lead, 52% follow
- Last fund: May invest from a new fund soon — raised $250M in 2018
Portfolio highlights
- Tacalyx — Tacalyx develops therapeutics targeting cancer-specific carbohydrate antigens on the surface of metastatic malignant tumors where no satisfactory treatments exist.The name Tacalyx is derived from TACA (Tumor Associated Carbohydrate Antigen) and ‘lyx’ from the term Glycocalyx, the glycan-containing layer covering cells. Cancer cells differ fromnormal cells by displaying aberrant carbohydrate structures on their surfaces promoting metastasis, angiogenesis or suppression of the immune system. TACAs result from the aberrant glycosylation that is seen with transformation to a tumor cell and represent attractive targets for cancer treatment since they are displayed with high cancer specificity and enhance tumor virulence via the mentioned diverse mechanisms.
- smartbax — We develop novel multi-targeted, antibacterial compounds with extraordinary potency against multi-drug resistant bacteria and difficult-to-treat biofilms.
- Cloverleaf Bio — Cloverleaf Bio | Developing a new class of RNA therapeutics to revolutionize cancer therapy.
Crowberry Capital invests at seed and early stage in emerging technology ventures in the Nordics. Our mission is to back people that are good for companies and build companies that are good for people. We have a strong follow-through philosophy and commit to putting your company first.
Show more...Investment focus
- Industry: Software, Gaming, Health Care
- Stage:Seed, Series A, Pre-Seed
- Geography: Iceland, Denmark, Finland
Investor stats
- Total investments: 52
- Round size: Seed $1.6M–$4.4M; Pre-Seed $400k–$1.3M; Series A $5.7M–$17M
- Lead/follow: 46% lead, 54% follow
- Last fund: Likely still investing — raised $90M in 2021
Portfolio highlights
- Quanscient — Quanscient develops multiphysics simulation software utilizing quantum computing algorithms to improve simulation technology. Its Computer Aided Engineering (CAE) platform integrates a unique combination of cloud-native multiphysics solvers, advanced cloud computing, and future quantum integration. The platform also offers engineers over ahundredfold increase in simulation throughput to enable fully digital R&D processes, addressing complex technology challenges in industries like fusion energy, 6G/7G, advanced semiconductors, biomedical, automotive, and aerospace.
- SNERPA Power — SNERPA Power develops intelligent energy services.
- Augmented Hearing — Read more about danish audiology scale-up Augmented Hearing, driving the world's most ambitious audiology solutions and innovations.
Voima Ventures’ mission is to solve major global problems by combining science, entrepreneurship, and value adding capital. They shed light on the ideas and technology which require time and courage to build. Industry domains include bio and new materials, medical technologies and life sciences, imaging and optics, IoT and electronics, robotics,software & ICT and AI. In addition, Voima Ventures has invested in more than 30 deep tech startups, including companies like Solar Foods, Infinited Fiber Company, and Dispelix. Cornerstone investors are VTT Technical Research Centre of Finland and European Investment Fund (EIF), backed by Finnish private and institutional investors.
Show more...Investment focus
- Industry: Biotechnology, Health Care, Artificial Intelligence
- Stage:Seed, Pre-Seed, Series A
- Geography: Finland, Sweden, Norway
Investor stats
- Total investments: 61
- Round size: Seed $1M–$5.9M; Pre-Seed $464k–$2.1M; Series A $3.9M–$30M
- Lead/follow: 64% lead, 36% follow
- Last fund: Likely still investing — raised $108M in 2023
Portfolio highlights
- Reduciner — Reduciner's vision to turn industrial CO₂ emissions from a liability into a valuable resource. Its technology converts captured carbon dioxide and biochar into valuable feedstocks such as carbon monoxide and activated carbon, enabling circular carbon use in emissions-intensive industries. Reduciner combines strong scientific expertise withindustrial applicability across sectors such as cement, steel, and chemicals. Its electricity-driven process allows industries to reduce emissions without major changes to existing infrastructure, offering a resilient and cost-competitive way to reduce carbon dependency while creating new value from CO₂ emissions.
- TheStorage — Flexible industrial heat electrification and scalable energy storage. TheStorage offers cost efficient, sustainable grid scale energy storage that can discharge heat, steam or CHP.
- Photoncycle — The year-round solar energy system for heating and electricity
Bånt AB
Show more...Investment focus
- Industry: Biotechnology, Manufacturing, Food Processing
- Stage:Seed
- Geography: Sweden
Investor stats
- Total investments: 3
- Round size: Seed $1.3M–$9.1M
- Lead/follow: 0% lead, 100% follow
Portfolio highlights
- Mycorena — Mycorena is a fungi-based, next-generation vegan protein and food manufacturing solution to plants, using significantly less resources. Mycorena was established in 2017 and is headquartered in Gothenburg, Sweden.
EIR Ventures is a new Life Science Venture Group in the Nordics.
Show more...Investment focus
- Industry: Biotechnology, Health Care, Therapeutics
- Stage:Series A, Seed
- Geography: Denmark, Sweden, United States
Investor stats
- Total investments: 13
- Round size: Series A $20M–$73M
- Lead/follow: 54% lead, 46% follow
- Last fund: Likely still investing — raised $138M in 2021
Portfolio highlights
- ArgusEye — ArgusEye is a biotechnology company that provides sensor solutions for real-time detection of biological systems and processes. ArgusEye's patented sensor technology is the result of extensive academic research and is based on nanoplasmonic sensing with fiber optics. By adding customized receptors, ArgusEye can offer flexible and sensitivesensing systems for a variety of targets.
- Moleculent — Moleculent is adding a functional layer of biology to pave the way for unparalleled advancements in biological research.
- Hoba Therapeutics — Hoba Therapeutics is developing a new therapeutic protein for the treatment of neuropathic pain.
We help great minds unleash their full potential!
Show more...Investment focus
- Industry: Software, SaaS, Energy
- Stage:Seed, Venture - Series Unknown, Pre-Seed
- Geography: Sweden, Denmark, Finland
Investor stats
- Total investments: 37
- Round size: Seed $854k–$3.7M; Pre-Seed $826k–$8.2M; Venture - Series Unknown $1.3M–$40M
- Lead/follow: 59% lead, 41% follow
- Last fund: Likely still investing — raised $52M in 2022
Portfolio highlights
- Tavion — Critical energy storage infrastructure for a sustainable future.
- SNERPA Power — SNERPA Power develops intelligent energy services.
- Helios Innovations — Helios offers on-site industrial waste management of liquid waste. Reduce waste volume by up to 90% without investment.
Access 48,091 investors
822 industries, 177 countries. Updated daily. Emails and phones included.
Browse database — It's Free!I Love Lund is a venture capital firm.The firm seeks opportunities to invest in pre-seed rounds
Show more...Investment focus
- Industry: Biotechnology, Medical, Forestry
- Stage:Venture - Series Unknown, Pre-Seed, Seed
- Geography: Sweden
Investor stats
- Total investments: 7
- Round size: Pre-Seed $420k–$456k; Venture - Series Unknown $38k–$2.2M
- Lead/follow: 43% lead, 57% follow
Portfolio highlights
- Cyclicor — Cyclicor is an innovations based company focused on the development and commercialisation of safer and more sustainable polymers. The company was registered in October of 2012 as a spin-off company from the University of Lund in Sweden and began commercial development of its first product Cycli-ClearTM, a bisphenol free polycarbonate, in late 2013.
- Katam Technologies — Katam Technologies helps forestry companies all over the world optimize operations through digitalization, solid data, and planning. With the aid of digitalization, reliable data, and careful planning, Katam assists forestry companies all over the world in maximizing operations. Small businesses and private forest owners can use the Katam app orKatam portal as standalone products to obtain quick and precise measurements.
- Valkyr Defense Systems — Valkyr specializes in cost-effective, modular, and autonomous defense systems, leveraging commercial off-the-shelf (COTS) technology to fast-track production.
Since 2005, Inventure has backed over 90 companies including Wolt, Swappie, Jobbatical, aiMotive, and more.
Show more...Investment focus
- Industry: Software, Information Technology, Health Care
- Stage:Seed, Series A, Series B
- Geography: Finland, Sweden, United States
Investor stats
- Total investments: 179
- Round size: Seed $549k–$6M; Series A $1.3M–$17M; Series B $1.3M–$25M
- Lead/follow: 47% lead, 53% follow
- Last fund: Likely still investing — raised $140M in 2022
Portfolio highlights
- Lassie — Lassie is the first proactive and preventive pet insurance company that wants to help pet owners take better care of their pets
- Capalo AI — We maximize the value of your energy storage systems. Now and in the future.
- Algorithmiq — Algorithmiq utilizes its expertise in quantum information, complex systems, and computational physics to develop algorithms to develop new and effective drugs, solve problems in life sciences, and discover new materials.
Partnerinvest Norr is a private equity firm specialized in software, security, and biometrics sectors. Partnerinvest Övre Norrland AB is a venture capital firms that seeks to invest in limited companies which have are in the expansion phase.
Show more...Investment focus
- Industry: Software, Manufacturing, Information Technology
- Stage:Seed, Venture - Series Unknown
- Geography: Sweden, United States
Investor stats
- Total investments: 70
- Round size: Seed $560k–$2M; Venture - Series Unknown $326k–$6.1M
- Lead/follow: 16% lead, 84% follow
- Last fund: May invest from a new fund soon — raised $32M in 2009
Portfolio highlights
- Cold River Games — Crystalfall is an upcoming free online action RPG with customizable skills and an endless endgame, set in a steampunk world.
- Original Creation — Original Creation envisions a sustainable future in which capital is focused on long-term benefits for both people and the environment, and resources are properly managed through circular systems."
- Remos Space Systems — Remos Space Systems simplifies satellite ground operations.
Gunnar Nilsson Cancer Foundation
Show more...Investment focus
- Industry: Medical, Genetics, Biotechnology
- Stage:Seed, Series A
- Geography: Sweden
Investor stats
- Total investments: 2
- Lead/follow: 0% lead, 100% follow
Portfolio highlights
- SAGA Diagnostics — SAGA Diagnostics AB is a personalized cancer diagnostics and disease monitoring company focused on molecular genetic analyses of a powerful cancer biomarker: circulating tumor DNA (ctDNA). The company was founded in 2016 as a spin-out from a highly successful research group at Lund University, with a mission to improve precision cancer medicine,provide more accurate treatment monitoring, and improve patient survival using minimally-invasive liquid biopsy cancer testing services and kits.The SAGA team consists of renowned scientists, highly qualified staff and an experienced management team who work together to launch SAGA’s ultrasensitive services and products as part of the ongoing revolution in cancer research, drug development, and clinical diagnostics. SAGA’s proprietary tests can help patients, oncologists, and drug developers detect actionable mutations, stratify patient groups, and monitor treatment response, residual disease, and disease recurrence at an unprecedented sensitivity.
Glass Wall Syndicate invests in companies and products that will make a difference in the lives of animals, people, and the planet. It helps grow companies in this space by providing them with capital, resources, mentorship, and other forms of support.The firm is consists of a group of venture capitalists, foundations, trusts, non-profits, andindividual investors who share a similar investment thesis and want to accelerate mainstream adoption of products and services that will make a difference in the lives of animals, people and that are better for the planet.
Show more...Investment focus
- Industry: Biotechnology, Food and Beverage, Health Care
- Stage:Seed, Pre-Seed, Series C
- Geography: United States, India, Sweden
Investor stats
- Total investments: 8
- Round size: Seed $845k–$5.7M; Pre-Seed $1.6M–$2M
- Lead/follow: 0% lead, 100% follow
Portfolio highlights
- MeliBio — Discover MeliBio's innovative bee-free honey, promoting a sustainable future for humans and bees. Explore our mission, vision, and impact.
- Cultured Decadence — Growing real meat directly from animal cells.
- UNCAGED Innovations — What if we could make leather without the animal? We are a biomaterials company combining the power of nature and technology to reimagine leather.
Value creation for Healthcare & Life Sciences Ventures through capital, expertise, international network.
Show more...Investment focus
- Industry: Health Care, Biotechnology, Medical
- Stage:Series A
- Geography: United Kingdom, Sweden
Investor stats
- Total investments: 7
- Round size: Series A $4.3M–$12M
- Lead/follow: 0% lead, 100% follow
Portfolio highlights
- Orthox Ltd. — Founded to commercialise technology developed at Oxford University, Orthox aims to revolutionise the way cartilage injuries are treated. Trauma and erosion of the smooth, stiff cartilage in our joints leads to Osteoarthritis (OA) a debilitating disease, which affects over 300 million patients globally and costs the US economy alone over $128billion each year. Current therapies to repair damaged cartilage focus either on tissue regeneration or on functional replacement; Orthox’s exceptionally strong, resilient, regenerative hydrogel technology, FibroFix™ achieves both these goals, offering a unique solution for the millions of patients suffering from damage to their joints. Initially targeting the knee, Orthox has developed a compelling set of data on lead product FibroFix™ Cartilage which has secured major awards from multiple funding bodies and will shortly enter clinical trials. FibroFix™ technology will then be rolled out to treat other joints and Orthox also has pipeline developments beyond orthopaedics in which strength and tissue regeneration are key. Pipeline expansion is valuable as growth in the annual global biomaterials market will exceed $250 billion by 2025. Orthopaedic biomaterials will form the largest proportion of this and natural biomaterials, like FibroFix™, will be the fastest growing market segment. Orthox: Reducing Pain, Increasing Mobility, Regenerating Strength™.
- Gedea Biotech — Gedea Biotech develops an antibiotic-free, safe and effective treatment of vaginal fungal infections. Vaginal yeast infections are a major problem that affects about 75% of all women at some point in life. Gedea Biotech's substance, GA101, is a natural substance that has always been part of their environment. It acts by lowering the pH as wellas providing a physical barrier protection and inhibiting biofilm formation. The first product will be a topical treatment of vaginal fungal infections.
- Oxford Endovascular — Oxford Endovascular are developing a novel treatment for treating brain aneurysms. The Oxford technology uses a special laser-cut metal alloy which has a shape-memory. It can be posted into a catheter during surgery, inserted into the brain and opened up into a tiny tube mesh (‘flow diverter’) that fits into the natural shape of the blood vessel.This diverts the blood away from the aneurysm, allowing it to heal.
FARO is an Argentina company over 10 years of experience in the development and operation of integrated projects in the agribusiness sector. All projects FARO own position it as a reference and leader both locally and internationally.Among his various projects, FARO operates the largest tree planting pecan nut Latin America, with projection tobecome the largest southern hemisphere and one of the largest in the world. This project is structured under different vehicles, including Alto Pecan stands, the first real estate development of nautical fields planted with pecan nut Latin America, located in Villa Paranacito, Entre Ríos . Another project is AgroConsortium, productive trust for the production and marketing of cereals and oilseeds in leased farms located in different productive areas in Argentina and potentially in the region. Finally, thanks to the expertise acquired in agribusiness, FARO developed his own business model for productive land conversion. Its aim is to position rural properties whose productive potential is not reflected in the price and complement the cycle with the economic use of land in intensive production, short and medium term.Since 2006, the Investor Group is a strategic partner OMBU FARO for all investment portfolios development ventures related to agribusiness, that focus on supply both local and international markets.
Show more...Investment focus
- Industry: Biotechnology, Gaming, Medical
- Stage:Series A, Seed, Venture - Series Unknown
- Geography: Sweden, United States
Investor stats
- Total investments: 5
- Round size: Series A $2.8M–$25M
- Lead/follow: 20% lead, 80% follow
- Last fund: May invest from a new fund soon — raised $115M in 2014
Portfolio highlights
- Bionamic — Bionamic provides solutions for the analysis of life science data to reduce or eliminate the manual steps between raw data and results.
- Bluwhale — Unlock Web3 Wallet Potential with AI Insights. Supercharge Your Business Growth
- IntuiCell — IntuiCell develops a fundamentally new recursive computing architecture and associated technology platform.
LU Holding is a Lund University’s investment company.
Show more...Investment focus
- Industry: Biotechnology, Software, Medical Device
- Stage:Seed, Angel, Pre-Seed
- Geography: Sweden
Investor stats
- Total investments: 4
- Lead/follow: 25% lead, 75% follow
Portfolio highlights
- MedVasc — MedVasc has developed Solution a patented medical device that reduces pain when treating varicose veins.
- Bionamic — Bionamic provides solutions for the analysis of life science data to reduce or eliminate the manual steps between raw data and results.
- Trackpaw Scientific — Contributing to the development of safe and effective pharmaceuticals at increased speed and quality by digitalising the preclinical study landscape.
Colibri Ventures invest in early-stage life science companies and help accelerate their innovations into commercial products.
Show more...Investment focus
- Industry: Gaming, Finance, Wellness
- Stage:Seed, Series A, Venture - Series Unknown
- Geography: Sweden, Mexico
Investor stats
- Total investments: 4
- Round size: Seed $6M–$6M
- Lead/follow: 0% lead, 100% follow
Portfolio highlights
- Mundi — Mundi provides financial, trade development, strategy, freight and reinventing international trade services.
- Mindforce Game Lab — Mindforce Game Lab creates meaningful games with characters that act as companions on the journey to better health.
- Pixelgen Technologies — Understand the role of proteins in cellular organization with spatial proteomics. Get ahead in the field of proteomics with us.
We partner with founders to transform unseen scientific discoveries into future breakthroughs, jointly moving businesses, people, and the world forward.
Show more...Investment focus
- Industry: Biotechnology, Medical, Health Diagnostics
- Stage:Seed, Pre-Seed, Series A
- Geography: Finland, Sweden, United States
Investor stats
- Total investments: 17
- Round size: Seed $373k–$4.6M; Pre-Seed $380k–$837k; Series A $2.9M–$3.9M
- Lead/follow: 88% lead, 12% follow
- Last fund: Likely still investing — raised $34M in 2024
Portfolio highlights
- CubaseBio — Cubase Bio is a biotechnology business that focuses on spatial biology tools. It creates solutions for 3D spatial analysis to speed up drug discovery.
- mu-ray.tech — MuRay Tech generates a controlled muon beam to image inside solid metal and 3D printed pieces. Non-destructively. In minutes.
- Perfat Technologies — Perfect fats for better foods.
Access 48,091 investors
822 industries, 177 countries. Updated daily. Emails and phones included.
Browse database — It's Free!ARCH Venture Partners provides seed / early stage venture capital for technology firms in information technology, life sciences, and physical sciences
Show more...Investment focus
- Industry: Biotechnology, Health Care, Therapeutics
- Stage:Series A, Series B, Series C
- Geography: United States, China, United Kingdom
Investor stats
- Total investments: 467
- Round size: Series A $8.4M–$216M; Series B $15M–$230M; Series C $15M–$167M
- Lead/follow: 31% lead, 69% follow
- Last fund: Likely actively investing — fresh fund, raised $3B in 2024
Portfolio highlights
- Synchron — The endovascular brain computer interface.
- Parabilis Medicines — Parabilis Medicines is a biopharmaceutical company in the clinical stage that focuses on developing exceptional medications targeting challenging protein structures previously deemed undruggable. Utilizing more than ten years of exclusive data, innovative laboratory techniques, and algorithms based on AI and physics, the company has introduced anovel category of stabilized, cell-penetrating alpha-helical peptides known as Helicons™. These peptides can modulate intracellular proteins that traditional drug modalities cannot reach.
- Moonwalk Biosciences — By deeply profiling and targeting the epigenetic code, Moonwalk aims to reprogram cells to their healthy state, fundamentally enabling a new approach to how therapies are discovered and developed.
Segulah Medical Acceleration is a Scandinavia-based investment company focusing on innovative medical technology companies in Europe.
Show more...Investment focus
- Industry: Health Care, Medical Device, Biotechnology
- Stage:Series D, Series A, Seed
- Geography: Sweden, United Kingdom, Germany
Investor stats
- Total investments: 9
- Round size: Series A $8.5M–$12M; Series D $34M–$245M
- Lead/follow: 67% lead, 33% follow
Portfolio highlights
- Protembis — ProtEmbo is designed to be a simple and reliable solution for one of the most feared complications during TAVR.The advent of transcatheter treatments for valvular heart disease has been a major revolution in the care of patients with disabilities or intercurrent illnesses that precluded undergoing stressful open cardiac surgical procedures.Nonetheless, in spite of ongoing improvements in TAVR procedures and outcomes, the occurrence of cerebrovascular events represents a significant morbidity of TAVR.Protembis was founded based on the vision to reduce the risk of cerebrovascular events, thereby improving outcomes and making TAVR even safer – especially in light of TAVR shifting to younger and lower-risk patients. The ProtEmbo System is an adjunctive device used during TAVR and removed following completion of valve implantation. The ProtEmbo is an intra-aortic filter device that is designed to deflect embolic material arising during TAVR away from the cerebral circulation.
- Navinci Diagnostics — Navinci is a Swedish biotech company specializing in innovative in situ proximity ligation assay-based solutions for spatial proteomics.
- Collective Minds — Collective Minds develops and delivers a cloud-based collaboration platform for healthcare and research with access to data, human and digital expertise.
Noaber Ventures invests in initiatives that bring social transformations using information technology.
Show more...Investment focus
- Industry: Health Care, Medical, Fitness
- Stage:Seed, Series A, Pre-Seed
- Geography: The Netherlands, Israel, Germany
Investor stats
- Total investments: 20
- Round size: Seed $423k–$6.3M; Series A $3M–$20M
- Lead/follow: 25% lead, 75% follow
Portfolio highlights
- Plasmacure — Plasmacure develops innovative plasma technology for wound care. Discover how cold plasma is transforming the treatment of chronic wounds.
- Mirantus Health — Mirantus is building a distributed healthcare provider to improve access to care for underserved patients. Through healthcare services (Mirantus Care) and cloud-solutions (Mirantus OS), Mirantus empowers doctors to efficiently treat patients who were difficult to reach before. This improves healthcare access for patients, allows physicians to earnmore, while saving payors billions in downstream costs. Mirantus is on a mission to get every specialist physician in Europe to participate in distributed healthcare, to improve healthcare access for 100M+ underserved patients.
- Alba Health — Discover your baby's gut health & microbiome for the best start in life.
LSI Academy - New education 2026, read more here
Show more...Investment focus
- Industry: Medical, Biotechnology, Biopharma
- Stage:Seed, Pre-Seed
- Geography: Sweden
Investor stats
- Total investments: 6
- Round size: Seed $682k–$4.6M; Pre-Seed $310k–$500k
- Lead/follow: 0% lead, 100% follow
Portfolio highlights
- Haga Bioscience — Mission Technology Assays Benefits Team Contact us Focus whereit truly matters. In situ RNA detection at single nucleotide resolution, bridging discovery and translation. Our mission Bridging discovery and translation Spatial omics technologies have transformed how we study tissue biology.However, translating these discoveries into robust, actionable biomarkers remains a major bottleneck, limited by a lack of
- CubaseBio — Cubase Bio is a biotechnology business that focuses on spatial biology tools. It creates solutions for 3D spatial analysis to speed up drug discovery.
- SampleFacts — Next generation Dried Blood Spot sampling – separating cells and plasma at the point of collection.
Länsförsäkringar is a Swedish group of public insurance companies.
Show more...Investment focus
- Industry: Real Estate, Biotechnology, Manufacturing
- Stage:Seed, Pre-Seed, Post-IPO Equity
- Geography: Sweden
Investor stats
- Total investments: 12
- Round size: Seed $484k–$1.3M; Post-IPO Equity $48M–$107M
- Lead/follow: 17% lead, 83% follow
Portfolio highlights
- Stendorren Fastigheter — Stendorren Fastigheter is a company involved in the real estate industry. It develops, owns, operates, and maintains industrial, logistical, and warehouse facilities. The business offers adequate and suitable space on fair lease terms through its tenant.
- pixlbio (formerly Phenaros) — Data-centric drug discovery with AI, Phenomics and Automation.
- Swedish Logistic Property — Swedish Logistic Property (SLP) specializes in the development and management of logistics properties across Sweden. With a focus on energy efficiency, SLP provides modern logistics solutions tailored to meet the needs of various businesses. The company's portfolio includes strategically located properties designed to support efficientlogistics and supply chain operations. SLP also engages in the acquisition and development of new properties, aiming to expand its footprint in the logistics real estate market. The company's commitment to sustainability is evident in its construction practices and the operation of its logistics facilities.
Kale United offers a portfolio of over 75+ plant-based game changers
Show more...Investment focus
- Industry: Food and Beverage, Food Processing, Biotechnology
- Stage:Seed, Pre-Seed
- Geography: Sweden, United Kingdom, Canada
Investor stats
- Total investments: 28
- Round size: Seed $360k–$2.5M; Pre-Seed $100k–$2M
- Lead/follow: 7% lead, 93% follow
- Last fund: Likely still investing — fund raised in 2024
Portfolio highlights
- Opalia — Opalia is introducing a new era of dairy: functional, delicious, and sustainable dairy made from mammary cells.
- Hooked Foods — Hooked Foods is working on a plant-based tuna substitute. By serving delicious plant-based seafood for everyone to enjoy, the company is leading the transition to a healthier seafood ecosystem. The company was established in 2019 and is headquartered in Sweden.
- Cultimate Foods — At Cultimate, we are transforming the flavor and aroma industry with natural innovative ingredients.
Bertebos Foundation
Show more...Investment focus
- Industry: Biotechnology, Manufacturing, Food Processing
- Stage:Seed
- Geography: Sweden
Investor stats
- Total investments: 2
- Lead/follow: 0% lead, 100% follow
Portfolio highlights
- Mycorena — Mycorena is a fungi-based, next-generation vegan protein and food manufacturing solution to plants, using significantly less resources. Mycorena was established in 2017 and is headquartered in Gothenburg, Sweden.
We deploy early stage capital to fuel the growth of need-driven health technology companies.
Show more...Investment focus
- Industry: Health Care, Artificial Intelligence, Software
- Stage:Seed, Pre-Seed, Series A
- Geography: United States, United Kingdom, Germany
Investor stats
- Total investments: 96
- Round size: Seed $2M–$6.3M; Pre-Seed $529k–$2.4M; Series A $5M–$21M
- Lead/follow: 43% lead, 57% follow
- Last fund: Likely actively investing — fresh fund, raised $52M in 2025
Portfolio highlights
- Biobase — Biobase is the agentic system for clinical data, closing the gap between clinical data and better healthcare.
- Ladder Health — Ladder Health offers virtual pediatric therapy and support for early childhood developmental delays, including speech and physical therapy.
- Woodway Assurance — Woodway Assurance provides EviData, an AI-driven software for automated privacy assurance on de-identified and synthetic datasets.
LIU invests in companies that are based on projects and ideas from Linköping University. LIU Invest is focused on investments in early phases. Investments are typically 250 000, but can be doubled by an additional investment.
Show more...Investment focus
- Industry: Biotechnology, Information Technology, AgTech
- Stage:Seed, Pre-Seed
- Geography: Sweden
Investor stats
- Total investments: 9
- Round size: Seed $579k–$1.4M; Pre-Seed $88k–$282k
- Lead/follow: 0% lead, 100% follow
Portfolio highlights
- Cellfion — Cellfion provides sustainable materials for next level clean energy storage and conversion devices.
- Sonicflora — Plants have always been speaking. We can now understand them.
- Polar Light Technologies — Polar Light Technologies focuses on developing the next generation of Nano and micro LED technology.
Plantbase Foundation
Show more...Investment focus
- Industry: Biotechnology, Manufacturing, Food Processing
- Stage:Seed
- Geography: Sweden
Investor stats
- Total investments: 2
- Lead/follow: 0% lead, 100% follow
Portfolio highlights
- Mycorena — Mycorena is a fungi-based, next-generation vegan protein and food manufacturing solution to plants, using significantly less resources. Mycorena was established in 2017 and is headquartered in Gothenburg, Sweden.
Access 48,091 investors
822 industries, 177 countries. Updated daily. Emails and phones included.
Browse database — It's Free!KTH Holding is a state-owned limited company managed by KTH's University Board. It invests in promising startup companies that are based on research or teaching at KTH, with the aim of supporting commercialization and making it easier for new science to benefit society.
Show more...Investment focus
- Industry: Software, Information Technology, Biotechnology
- Stage:Seed, Pre-Seed
- Geography: Sweden
Investor stats
- Total investments: 21
- Lead/follow: no public data
Portfolio highlights
- Cellfion — Cellfion provides sustainable materials for next level clean energy storage and conversion devices.
- porkchop — In-space logistics for SmallSats in Low Earth Orbit and beyond.
- Novatron — A new fusion reactor design for stable plasma confinement and fusion power generation.
We are investing in #FutureFood. Nordic FoodTech VC is the first fund in the Nordics investing explicitly in the future of food
Show more...Investment focus
- Industry: Biotechnology, Life Science, Water
- Stage:Seed, Series A
- Geography: Finland, Sweden, Denmark
Investor stats
- Total investments: 26
- Lead/follow: no public data
Portfolio highlights
- EvodiaBio — Mirroring nature with pioneering bioscience for natural flavors
- Endless Food — Endless Food Co is a food innovation firm focusing on the junction of pleasure and sustainability. Endless Food Co was pulled together by a common idea that the transition to a greener and more egalitarian future food system will be driven by flavor, and having spent the last decade pioneering sustainable gastronomy
- Happy Plant Protein — Revolutionize plant protein production with Happy Plant Protein's innovative technology, transforming local ingredients into high-quality, sustainable solutions for the food industry.
Knutsson Holdings AB is an family owned private equity firm.
Show more...Investment focus
- Industry: Gaming, Billing, Parking
- Stage:Series C
- Geography: Sweden, Germany
Investor stats
- Total investments: 4
- Lead/follow: no public data
Portfolio highlights
- Drifter — Drifter stays abreast of the latest technological trends in offering practical solutions for the parking and EV charging ecosystem.
- Unicorn Workspaces — Unicorn offers work solutions for teams of all sizes with flexible terms and independent of high market rental prices. It is a fast-growing shared office provider, with 21 workspaces in Berlin, Potsdam, Cologne, Munich, Hamburg, and LisbonTheir vision of “Workspace as a Service” is reflected in their all-inclusive offer, and support fromcommunity baristas. They combine their coffee expertise and community manager knowledge to provide seamless work experience. With their friendly attitude and eagerness to help, members and visitors will receive good advice and assistance.Each of their workspaces is equipped with a modern café, where they offer organic direct trade coffee and hot beverages for all of their members and guests. They also offer a small selection of cold drinks, salads, and desserts. The café functions as a central meeting point for their community.
- Resolution Games — Resolution Games is a Stockholm based studio focused on creating virtual reality (VR) and augmented reality (AR) immersive experiences for all.
On Sätila Holding, They are constantly looking for exciting new business ideas. They invest in start up, buy-out, expansion and reorganization. They go in as partners and their investments tend to be between 1 and 10 million.
Show more...Investment focus
- Industry: Biopharma, Health Care, Biotechnology
- Geography: Sweden
Investor stats
- Total investments: 1
- Lead/follow: 0% lead, 100% follow
Portfolio highlights
- Adenovir Pharma — Adenovir Pharma AB is a development company developing new solutions for treatment of infectious diseases affecting the eyes.Adenovir Pharma was founded by researchers at the department of Virology, UmeÃ¥ University, Sweden and P.U.L.S. AB which acts as an incubator and financer for early stage projects within life science. Adenovir Pharma islocated in Helsingborg Sweden in one of Europe’s premier biotechnology regions, Medicon Valley. The initial development has been conducted at the University of Lund, Department of Organic Chemistry and at the University of UmeÃ¥, Department of Virology and in collaboration with P.U.L.S. AB and external service providers.With unique patented technology and own product concepts, Adenovir Pharma aim to offer new treatments and business development opportunities to the pharmaceutical industry. The goal is to develop a new antiviral medicinal product for the treatment and prevention of epidemic keratoconjunctivities (EKC).
Falkenbergs Sparbanks Foundation
Show more...Investment focus
- Industry: Biotechnology, Manufacturing, Food Processing
- Geography: Sweden
Investor stats
- Total investments: 1
- Lead/follow: 0% lead, 100% follow
Portfolio highlights
- Mycorena — Mycorena is a fungi-based, next-generation vegan protein and food manufacturing solution to plants, using significantly less resources. Mycorena was established in 2017 and is headquartered in Gothenburg, Sweden.
LubioScience is Switzerland's biggest Life Sciences distributor. 120+ high quality suppliers, 4.5 million research products. Next day carbon-neutral delivery.
Show more...Investment focus
- Industry: Therapeutics, Biotechnology, Medical Device
- Geography: Sweden
Investor stats
- Total investments: 1
- Lead/follow: 0% lead, 100% follow
Portfolio highlights
- Cantargia — The company is based on the original discovery that leukemic stem cells in patients with chronic myeloid leukemia (CML) express a cell-surface receptor, whereas corresponding normal hematopoietic stem cells do not express this receptor. Stem cells from patients with acute myeloid leukemia (AML) and acute lymphocytic leukemia (ALL) has also beenshown to have and upregulation of the receptor. Cantargia uses this receptor, the Interleukin-1 receptor accessory protein (IL1RAP), as the target for development of a novel antibody-based therapy for leukemia
Kurma Partners is a management company based in Paris, specializing in the financing of innovation in healthcare and biotechnology, from pre-creation to development capital. Kurma Partners, which manages the Kurma Biofund I, II funds and the Kurma Diagnostics fund, is one of the main players in the financing of therapeutic and medical innovationsin Europe, particularly through links with many institutes. research and prestigious hospitals.
Show more...Investment focus
- Industry: Health Care, Biotechnology, Medical
- Stage:Series A, Seed, Series B
- Geography: France, Switzerland, Spain
Investor stats
- Total investments: 145
- Round size: Seed $2.7M–$14M; Series A $3.9M–$98M; Series B $12M–$72M
- Lead/follow: 48% lead, 52% follow
- Last fund: Likely actively investing — fresh fund, raised $236M in 2024
Portfolio highlights
- EvlaBio — EvlaBio is a biotech company focused on the development of drug programs that address significant unmet medical needs. The company's pipeline includes robust scientific antibody programs for the treatment of hepatocellular carcinoma (Phase 1 ready) and chronic kidney disease with left ventricular hypertrophy (pre-clinical).
- Nuevocor — Nuevocor is a preclinical-stage biopharmaceutical company focused on developing gene therapy‑based treatments that have the potential to restore cardiac function in diseased hearts.
- AM Pharma — AM-Pharma B.V., a biopharmaceutical company, engages in the development and commercialization of therapeutics for human use in the Netherlands. It focuses in the pre-clinical and clinical development of novel therapeutics to treat inflammatory and infectious diseases. The company develops products based on endogenous proteins and protein derivedpeptides, as well as molecules that naturally occur in the human body. Its products include alkaline phosphatase for treatment of acute kidney injury and ulcerative colitis; and immune response amplifying peptide hLF1-11 for the treatment of drug resistant hospital acquired infections. The company was founded in 2000 and is headquartered in Bunnik, the Netherlands.
Idinvest Partners is a pan-European private equity manager focused on the low and middle-market segments. With over 6 billion euros under management, the company has developed several complementary areas of expertise, including equity investments in buyout deals focusing on both mid-size as well as young innovative European companies; primaryinvestments in European private equity funds focusing primarily on the middle market segment; secondary investments; mezzanine investments in Europe; and private equity consulting.Idinvest Partners’ recent success stories include Criteo, Clear2Pay, Meetic, Prosensa, Converteam, Kwik Fit, Lastminute.com, Dailymotion, Deezer, Talend, Synthesio, Menlook, Vestiaire Collective, Pretty Simple, Curse.com, Withings, Kantox, Secret Escapes, Happn, Peakon, Dayuse, Botify, Financefox, Azalead and many more.
Show more...Investment focus
- Industry: Software, Health Care, Biotechnology
- Stage:Series A, Series B, Venture - Series Unknown
- Geography: France, United States, Germany
Investor stats
- Total investments: 336
- Round size: Series A $3.9M–$22M; Series B $7.8M–$66M; Venture - Series Unknown $4.1M–$65M
- Lead/follow: 40% lead, 60% follow
- Last fund: May invest from a new fund soon — raised $97M in 2021
Portfolio highlights
- Actility — Actility provides IoT connectivity and solutions to power smart cities and industries.
- Pretty Simple — Video games studio based in Paris, France. Makers of Criminal Case and Sorcery School.
- StarTower — StarTower is a resource company built specifically for fully decentralized physical infrastructure and shared interaction. Based on the exclusive RIP encryption technology, StarTower realizes the interactive sharing of multiple resources with zero loss on mobile devices, thereby providing efficient resource transmission for terminal facilities. Itprovides more efficient, secure and reliable solutions in the fields of Internet of Things, smart cities, industrial automation, healthcare, etc.
Irrus Investments is the leading Irish business angel network with international connections. Fueling Irish innovation in medical devices, software, hardware, digital healthcare and life sciences.
Show more...Investment focus
- Industry: Health Care, Medical Device, Biotechnology
- Stage:Seed, Venture - Series Unknown, Series A
- Geography: Ireland, Sweden, United States
Investor stats
- Total investments: 34
- Round size: Seed $713k–$4.7M; Series A $2.2M–$9.2M; Venture - Series Unknown $1.2M–$24M
- Lead/follow: 18% lead, 82% follow
Portfolio highlights
- Novus Diagnostics — Sepsis causing pathogen diagnostics under 15 minutes
- Vertigenius — Enhance patient care and treatment options for vertigo and dizziness with Vertigenius, enabling effective management and improved outcomes for your patients.
- Adama Innovations — Sharp Conductive Single Crystal Diamond AFM Probes
Sofinnova Partners is a leading European venture capital firm in life sciences, specializing in healthcare and sustainability. Based in Paris, London and Milan, the firm brings together a team of professionals from all over the world with strong scientific, medical and business expertise.
Show more...Investment focus
- Industry: Biotechnology, Health Care, Medical
- Stage:Series A, Series B, Series C
- Geography: France, United States, United Kingdom
Investor stats
- Total investments: 350
- Round size: Series A $7M–$70M; Series B $10M–$105M; Series C $12M–$100M
- Lead/follow: 47% lead, 53% follow
- Last fund: Likely actively investing — fresh fund, raised $755M in 2025
Portfolio highlights
- Odoo — From ERP to CRM, eCommerce and CMS. Download Odoo or use it in the cloud. Grow Your Business.
- Mironid — Google Analytics is a web analysis service provided by Google. Google utilizes the data collected to track and examine the use of www.mironid.com, to prepare reports on its activities and share them with other Google services. Google may use the data collected to contextualize and personalize the ads of its own advertising network.
- Forth Therapeutics — Forth Therapeutics is a biotechnology company dedicated to advancing precision treatments for fibrosis.
Biotechnology VC funding in Sweden at a glance
Stats across 425 deals from 325 investors.
Access all 325 VC funds in Sweden Biotechnology startups.
Open ListFAQ
Is Shizune data fresh/accurate?
Shizune has monitored hundreds of funding sources since 2020.
Our investor database is updated every day, so investor data is always fresh.
All metrics are calculated from confirmed public rounds, so the data is accurate.
Can I download investor list?
To download the Biotechnology VC Funds in Sweden investor list, create a Shizune account. This investor list will be added to your saved investors and available for download in the export section.
You can also enrich the investor list with investor emails, phones, LinkedIns, and other contact data.
Can I access investor database?
To access all 325 VC funds investing in Sweden Biotechnology startups and 48,091+ more investors, create a Shizune account.
Shizune has a database of 48,091 investors. Our investor database is fresh and updated daily.
The Shizune investor database has information on investor investment focus, investor contact data, and full investor portfolio since 2020.
You can enrich with email and download the data.
Does Shizune have investor emails and contacts?
Shizune enriches investors with contact data that includes: email, phones, LinkedIn, socials, website, and others.
To guarantee the highest discovery rate, we search across 20+ contact search tools.
To maximize delivery rate and reduce bounce rate, we validate emails.
You can enrich your investor list with Shizune. Download it too.
What is Shizune?
Shizune is a 48,091 investor database updated daily.
With Shizune you can:
- browse the database
- use smart matching
- enrich with emails
- download
All you need to find investors for your startup.
Who is Shizune for?
Shizune is built for startup founders by startup founders.
If you are looking for funding for your startup, try the Shizune database — we have investors for every stage, industry, and country.
Is Shizune free?
Shizune is free forever. You can search and browse investors for free.
Email search and export are paid features.
For full info, visit our pricing.
Who built Shizune?
Shizune is built by founders with the goal of helping all founders raise funding no matter where they are.
Contact 100 investors today
Find who invests in your industry, stage, and country. Download investor list with emails in 5 minutes.
Find investors — It's Free!